- Home
- RMTI vs GSIW Comparison
RMTI vs GSIW Comparison
Compare RMTI & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMTI | GSIW |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1M | 28.6M |
| IPO Year | 1998 | 2023 |
Fundamental Metrics
Financial Performance| Metric | RMTI | GSIW |
|---|---|---|
| Price | $0.83 | $0.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | 235.6K | ★ 284.7K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $75,577,000.00 | $5,368,221.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.12 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 283.23 |
| 52 Week Low | $0.78 | $0.09 |
| 52 Week High | $2.41 | $1.79 |
Technical Indicators
Market Signals| Indicator | RMTI | GSIW |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 38.96 |
| Support Level | $0.80 | $0.13 |
| Resistance Level | $0.89 | $0.14 |
| Average True Range (ATR) | 0.06 | 0.01 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 25.69 | 17.18 |
Price Performance
Historical ComparisonAbout RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.